PharmCADD is an artificial intelligence (AI) and physics-based company that develops an in-silico drug design platform designed to accelerate drug discovery meanwhile performing a design without building or maintaining the infrastructure associated with high-performance computational resources. PharmCADD leverages an AI and physics-based drug discovery platform technology called Pharmulator, which integrates five core modules: (1) protein 3D structure prediction (2) molecular dynamics simulation (3) quantum calculation (4) toxicity prediction and (5) AI drug generation, to generate potent but less toxic novel synthetic small molecules. The company aims to help scientists accelerate the search for a certain or specific drug candidate.